CompanyDeals

Innovent Biologics and Sanofi Announce License Deal for Drug Development in China

Company

Eli Lilly Reports First Quarterly Revenue Dip in Two Years, China Sales Plunge

Company

Novo Nordisk’s H1 2022 Results Show Strong Global Sales Growth, China Sales Dip

CompanyDeals

Shanghai Pharmaceuticals Partners with HKSTP and Shanghai Biomedicine Fund on R&D Collaboration

CompanyDrug

Zhongsheng Pharmaceutical Completes Phase I Study of RAY1216 for COVID-19 Treatment

CompanyDrug

CSPC Pharmaceutical’s rhTNK-tPA Meets Primary Endpoint in Stroke Study

CompanyDeals

HeNan Genuine Biotech Files for IPO to Fund Azvudine Commercialization

Company

Innovent Biologics’ Q2 2022 Revenues Surpass RMB 1 Billion, Seven Products Approved

CompanyDrug

Hybio Pharmaceutical’s HY3000 Nasal Spray for COVID-19 Enters NMPA Review

Company

GenScript’s Legend Biotech Appoints Three New Directors to Board

CompanyDrug

Boehringer Ingelheim Wins Patent Infringement Ruling Against HEC Over Trajenta

CompanyDrug

Zelgen’s Jacktinib Hits Phase IIb Endpoint in Myelofibrosis Study